NLRP3 and cystic fibrosis: In this study, an exaggerated pro-inflammatory response is seen in CF cells when challenged with NLRP3-inflammasome activators LPS and ATP, leading to increased IL-18 secretion in CF HBECs, and IL-1β and IL-18 in CF monocytes (Fig. 1) [28].